IRIS
FARINA, DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.161
EU - Europa 1.780
AS - Asia 1.692
SA - Sud America 224
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 38
OC - Oceania 3
Totale 6.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.049
CN - Cina 566
SG - Singapore 562
UA - Ucraina 259
IE - Irlanda 255
GB - Regno Unito 208
IT - Italia 196
RU - Federazione Russa 194
BR - Brasile 181
TR - Turchia 181
SE - Svezia 176
DE - Germania 164
FR - Francia 163
VN - Vietnam 148
FI - Finlandia 78
IN - India 78
CA - Canada 54
HK - Hong Kong 34
BD - Bangladesh 24
MX - Messico 19
CZ - Repubblica Ceca 18
AR - Argentina 17
JP - Giappone 17
PL - Polonia 14
ZA - Sudafrica 14
CR - Costa Rica 11
NL - Olanda 11
ES - Italia 10
IR - Iran 10
IL - Israele 9
IQ - Iraq 9
CO - Colombia 8
ID - Indonesia 8
CH - Svizzera 7
SC - Seychelles 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
PK - Pakistan 6
PY - Paraguay 6
EC - Ecuador 5
EU - Europa 5
JM - Giamaica 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
KR - Corea 4
NP - Nepal 4
RS - Serbia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AU - Australia 3
CL - Cile 3
GP - Guadalupe 3
GT - Guatemala 3
KE - Kenya 3
NI - Nicaragua 3
PR - Porto Rico 3
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
LB - Libano 2
MY - Malesia 2
PH - Filippine 2
SV - El Salvador 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
OM - Oman 1
RO - Romania 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 6.904
Salva come PNG Salva come JPEG
Città #
Singapore 424
Chandler 323
Jacksonville 309
San Jose 300
Dublin 253
Ashburn 181
Beijing 178
Dallas 170
Southend 152
Council Bluffs 125
Princeton 108
The Dalles 100
Izmir 92
Nanjing 89
Los Angeles 77
New York 59
Santa Clara 59
Dearborn 58
Wilmington 58
Munich 54
Ho Chi Minh City 53
Cambridge 49
Altamura 37
Tongling 36
Buffalo 34
Hanoi 33
Hong Kong 33
Nanchang 33
Moscow 29
Ann Arbor 28
Montreal 23
Shenyang 21
São Paulo 20
Denver 17
Brooklyn 16
Chieti 16
Washington 16
Frankfurt am Main 15
Turku 15
Atlanta 14
Carrboro 14
Hebei 14
Jiaxing 14
Kunming 14
Tianjin 14
Boardman 13
Hangzhou 13
Helsinki 13
Tokyo 13
Toronto 13
Woodbridge 13
Brno 12
Changsha 12
Chicago 12
Grevenbroich 12
Mexico City 12
Milan 12
Orem 12
Phoenix 12
Redondo Beach 12
Warsaw 12
Jinan 11
Columbus 10
Houston 10
Norwalk 10
Poplar 10
Guangzhou 9
Johannesburg 9
Rome 9
San José 9
Silver Spring 9
Stockholm 9
Ardabil 8
Augusta 8
Monmouth Junction 8
Amsterdam 7
Boston 7
Camerino 7
Chennai 7
Fermo 7
London 7
San Francisco 7
San Mateo 7
Campobasso 6
Charlotte 6
Da Nang 6
Fribourg 6
Hải Dương 6
Lanzhou 6
Manchester 6
North Bergen 6
Passaic 6
Rio de Janeiro 6
Amman 5
Biên Hòa 5
Brussels 5
Florence 5
Kimball 5
Leawood 5
Ningbo 5
Totale 4.255
Salva come PNG Salva come JPEG
Nome #
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 186
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 183
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 176
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 172
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 170
Increasing age at disability milestones among MS patients in the MSBase Registry 162
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 162
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 159
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 157
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 155
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 152
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 152
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 151
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 150
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 148
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 147
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 147
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 145
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 145
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 139
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 138
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 137
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 137
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 135
JCV-Ab serostatus in MS patients treated with Natalizumab 133
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 133
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 130
Interferone beta: effetti collaterali 128
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 128
Natalizumab-associated PML-IRIS: the Chieti experience. 126
Autologous HSCT for severe progressive Multiple Sclerosis in a multicenter trial: impact on disease activity and quality of life 124
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 124
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 124
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study 124
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. 124
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 121
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 118
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 118
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 117
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 115
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 107
Lymphomononuclear cells from multiple scerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. 105
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 105
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 105
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 102
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 102
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 99
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 99
Interferone beta1b: bilancio su un gruppo di 30 pazienti 98
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 96
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis 92
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 84
Long-term efficacy and tolerability of natalizumab treatment in multiple sclerosis patients: a multicentre experience in Italy 82
Totale 6.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.395
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 0 0 0 6 2 6 19 12 3 31 74
2022/2023806 58 122 45 83 86 164 40 56 108 6 23 15
2023/2024397 34 18 25 6 29 164 72 3 1 7 2 36
2024/2025893 60 99 111 13 13 31 19 31 62 43 197 214
2025/20262.140 191 80 250 323 225 106 359 93 220 153 94 46
2026/2027593 38 94 110 232 119 0 0 0 0 0 0 0
Totale 6.968